Takeuchi, T.; Okuno, T.; Miyashiro, A.; Kohda, T.; Miyamoto, R.; Izumi, Y.; Kozaki, S.; Kaji, R.
Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins. Toxins 2021, 13, 824.
https://doi.org/10.3390/toxins13110824
AMA Style
Takeuchi T, Okuno T, Miyashiro A, Kohda T, Miyamoto R, Izumi Y, Kozaki S, Kaji R.
Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins. Toxins. 2021; 13(11):824.
https://doi.org/10.3390/toxins13110824
Chicago/Turabian Style
Takeuchi, Toshiaki, Tsuyoshi Okuno, Ai Miyashiro, Tomoko Kohda, Ryosuke Miyamoto, Yuishin Izumi, Shunji Kozaki, and Ryuji Kaji.
2021. "Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins" Toxins 13, no. 11: 824.
https://doi.org/10.3390/toxins13110824
APA Style
Takeuchi, T., Okuno, T., Miyashiro, A., Kohda, T., Miyamoto, R., Izumi, Y., Kozaki, S., & Kaji, R.
(2021). Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins. Toxins, 13(11), 824.
https://doi.org/10.3390/toxins13110824
